Freeline Therapeutics Holdings plc Increase (Decrease) in Prepaid Expense and Other Assets
Freeline Therapeutics Holdings plc reported Increase (Decrease) in Prepaid Expense and Other Assets of -$916.00 thousand for the 9-month period ending 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2023-12-01
- Freeline Therapeutics Holdings plc increase (decrease) in prepaid expense and other assets for the quarter ending 2023-09-30 was -$2.27M, a 175.67% decline year-over-year.
- Freeline Therapeutics Holdings plc increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was -$844.00K.
- Freeline Therapeutics Holdings plc increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was $2.20M, a 34.43% increase year-over-year.
- Freeline Therapeutics Holdings plc increase (decrease) in prepaid expense and other assets for the quarter ending 2022-12-31 was -$2.73M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$2.27M derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | -$3.11M derived: sum of 2 quarters · filed 2023-12-01 | -$916.00K 6-K · filed 2023-12-01 | -$3.64M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-06-30 | -$844.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $1.35M 6-K · filed 2023-08-15 | -$1.37M derived: sum of 3 quarters · filed 2023-08-15 | $1.63M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-03-31 | $2.20M 6-K · filed 2023-05-30 | -$527.00K derived: sum of 2 quarters · filed 2023-05-30 | $2.47M derived: sum of 3 quarters · filed 2023-12-01 | -$245.00K derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-12-31 | -$2.73M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $275.00K derived: sum of 2 quarters · filed 2023-12-01 | -$2.44M derived: sum of 3 quarters · filed 2023-12-01 | -$808.00K 20-F · filed 2023-04-04 |
| 2022-09-30 | $3.00M derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | $282.00K derived: sum of 2 quarters · filed 2023-12-01 | $1.92M 6-K · filed 2023-12-01 | -$9.85M derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-06-30 | -$2.72M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | -$1.08M 6-K · filed 2023-08-15 | -$12.85M derived: sum of 3 quarters · filed 2023-08-15 | -$13.63M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | $1.64M 6-K · filed 2023-05-30 | -$10.13M derived: sum of 2 quarters · filed 2023-05-30 | -$10.91M derived: sum of 3 quarters · filed 2023-05-30 | -$15.37M derived: sum of 4 quarters · filed 2023-05-30 |
| 2021-12-31 | -$11.77M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | -$12.54M derived: sum of 2 quarters · filed 2023-04-04 | -$17.00M derived: sum of 3 quarters · filed 2023-04-04 | -$17.52M 20-F · filed 2023-04-04 |
| 2021-09-30 | -$775.00K derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15 | -$5.23M derived: sum of 2 quarters · filed 2022-11-15 | -$5.75M 6-K · filed 2022-11-15 | -$6.50M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-06-30 | -$4.46M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | -$4.97M 6-K · filed 2022-08-09 | -$5.72M derived: sum of 3 quarters · filed 2023-04-04 | -$2.05M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-03-31 | -$517.00K 6-K · filed 2022-05-10 | -$1.26M derived: sum of 2 quarters · filed 2023-04-04 | $2.41M derived: sum of 3 quarters · filed 2023-04-04 | $6.02M derived: sum of 4 quarters · filed 2023-04-04 |
| 2020-12-31 | -$748.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $2.93M derived: sum of 2 quarters · filed 2023-04-04 | $6.53M derived: sum of 3 quarters · filed 2023-04-04 | $11.88M 20-F · filed 2023-04-04 |
| 2020-09-30 | $3.68M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $7.28M derived: sum of 2 quarters · filed 2021-11-09 | $12.63M 6-K · filed 2021-11-09 | |
| 2020-06-30 | $3.60M derived: 6-K 6 month − 6-K 3 month · filed 2021-08-16 | $8.96M 6-K · filed 2021-08-16 | ||
| 2020-03-31 | $5.35M 6-K · filed 2021-05-17 | |||
| 2019-12-31 | $4.30M 20-F · filed 2022-03-31 | |||
| 2019-06-30 | $8.27M 6-K · filed 2020-10-29 | |||
| 2018-12-31 | $7.38M 20-F · filed 2021-03-31 |